Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Evopoint Biosciences Inc.
Evopoint Biosciences Inc.
Seagen Inc.
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Radiopharm Theranostics, Ltd
Terremoto Biosciences Inc.
Taiho Oncology, Inc.
GI Innovation, Inc.
Ensem Therapeutics
Mayo Clinic
Sun Yat-sen University
Eli Lilly and Company
Neonc Technologies, Inc.
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
Ascendis Pharma A/S
Qurient Co., Ltd.
AstraZeneca
National Institutes of Health Clinical Center (CC)
Amgen
Theravectys S.A.
Grey Wolf Therapeutics
TCRCure Biopharma Ltd.